Search Results - "Fukumoto, Motoi"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Disturbance in the regulation of miR 17-92 cluster on HIF-1-α expression contributes to clinically relevant radioresistant cells: an in vitro study by Roudkenar, Mehryar Habibi, Fukumoto, Motoi, Roushandeh, Amaneh Mohammadi, Kuwahra, Youshikazu, Uroshihara, Yusuke, Harada, Hiroshi, Fukumoto, Manabu

    Published in Cytotechnology (Dordrecht) (01-02-2020)
    “…Cellular radioresistance is one of the major obstacles to the effectiveness of cancer radiotherapy. In an attempt to elucidate the implication of HIF-1α and…”
    Get full text
    Journal Article
  7. 7

    TRPV4-dependent induction of a novel mammalian cold-inducible protein SRSF5 as well as CIRP and RBM3 by Fujita, Takanori, Higashitsuji, Hiroaki, Higashitsuji, Hisako, Liu, Yu, Itoh, Katsuhiko, Sakurai, Toshiharu, Kojima, Takahiro, Kandori, Shuya, Nishiyama, Hiroyuki, Fukumoto, Motoi, Fukumoto, Manabu, Shibasaki, Koji, Fujita, Jun

    Published in Scientific reports (23-05-2017)
    “…Cold-inducible RNA-binding protein (CIRP) and RNA-binding motif protein 3 (RBM3) are two evolutionarily conserved RNA-binding proteins that are structurally…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions by Moriya, Takuya, Kanomata, Naoki, Kozuka, Yuji, Fukumoto, Motoi, Iwachido, Nobuhisa, Hata, Sakae, Takahashi, Yayoi, Miura, Hiroshu, Ishida, Kazuyuki, Watanabe, Mika

    Published in Breast cancer (Tokyo, Japan) (01-07-2009)
    “…Immunohistochemistry (IHC) is routinely performed during pathology practice for various breast lesions. Hormone receptor and HER2 analysis for primary breast…”
    Get full text
    Journal Article
  12. 12
  13. 13

    ISG20 is overexpressed in clinically relevant radioresistant oral cancer cells by Miyashita, Hitoshi, Fukumoto, Motoi, Kuwahara, Yoshikazu, Takahashi, Tetsu, Fukumoto, Manabu

    “…Global standard fractionated radiotherapy (RT) for the treatment of malignancies consists of X-ray irradiation with 2-Gy/day, 5 days a week for 5-7 weeks…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Targeting of tumor endothelial cells combining 2 Gy/day of X‐ray with Everolimus is the effective modality for overcoming clinically relevant radioresistant tumors by Kuwahara, Yoshikazu, Mori, Miyuki, Kitahara, Shuji, Fukumoto, Motoi, Ezaki, Taichi, Mori, Shiro, Echigo, Seishi, Ohkubo, Yasuhito, Fukumoto, Manabu

    Published in Cancer medicine (Malden, MA) (01-04-2014)
    “…Radiotherapy is widely used to treat cancer because it has the advantage of physically and functionally conserving the affected organ. To improve radiotherapy…”
    Get full text
    Journal Article
  16. 16
  17. 17